Portal de Periódicos da CAPES

Practical applications of small intestine submucosa extracellular matrix (SIS-ECM) an expert panel consensus

2023; Mark Allen Group; Volume: 32; Issue: Sup9b Linguagem: Inglês

10.12968/jowc.2023.32.sup9b.s1

2052-2916

Ally‐Khan Somani, Leanne Atkin, Falk G. Bechara, Jeffrey M. Davidson, Steven Jeffery, Eliot N. Mostow, Richard Simman, David G. Armstrong, Angelos Karatzias, José Luis Lázaro‐Martínez, Jeanette Milne, Melina Vega de Céniga,

Surgical site infection prevention

Journal of Wound CareVol. 32, No. Sup9b Small Intestine Submucosa Extracellular MatrixPractical applications of small intestine submucosa extracellular matrix (SIS-ECM) an expert panel consensusAlly-Khan Somani, Leanne Atkin, Falk G Bechara, Jeffrey M Davidson, Steve Jeffery, Eliot Mostow, Richard Simman, David G Armstrong, Angelos Karatzias, José Luis Lázaro Martínez, Jeanette Milne, Melina Vega de CenigaAlly-Khan SomaniDirector of Dermatologic Surgery and Cutaneous Oncology Division; Assistant Professor, Department of Dermatology; and Adjunct Assistant Professor of Otolaryngology-Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, USSearch for more papers by this author, Leanne AtkinVascular Nurse Consultant, Mid Yorkshire Hospitals NHS Trust, Yorkshire, UKSearch for more papers by this author, Falk G BecharaHead of the Department of Dermatologic Surgery, Ruhr-University, Bochum, GermanySearch for more papers by this author, Jeffrey M DavidsonEmeritus Professor of Pathology, Microbiology and Immunology, Vanderbilt University, School of Medicine, Nashville, Tennessee, USSearch for more papers by this author, Steve JefferyProfessor of Wound Study, Birmingham, City University; Medical Director, Pioneer Wound, Telehealth, Birmingham, UKSearch for more papers by this author, Eliot MostowHead of the Dermatology Section, Northeast Ohio Medical University; Clinical Faculty, Case Western University, Ohio, USSearch for more papers by this author, Richard SimmanProfessor of Plastic Surgery, University of Toledo College of Medicine and Life, Sciences; Jobst Vascular Institute, ProMedica Health, System, Toledo, Ohio, USSearch for more papers by this author, David G ArmstrongProfessor of Surgery and Director of the Limb Preservation Program, University of Southern California, USSearch for more papers by this author, Angelos KaratziasPlastic, Reconstructive and Aesthetic Surgeon, Nicosia, CyprusSearch for more papers by this author, José Luis Lázaro MartínezTenured Professor and Clinical Director of the Diabetic Foot Unit, Complutense University of Madrid, SpainSearch for more papers by this author, Jeanette MilneClinical Lead for Tissue Viability, Northumbria Healthcare NHS Foundation Trust, UKSearch for more papers by this author, Melina Vega de CenigaConsultant Angiologist and Vascular and Endovascular Surgeon, Galdakao‑Usansolo Hospital, Bizkaia, SpainSearch for more papers by this authorAlly-Khan Somani; Leanne Atkin; Falk G Bechara; Jeffrey M Davidson; Steve Jeffery; Eliot Mostow; Richard Simman; David G Armstrong; Angelos Karatzias; José Luis Lázaro Martínez; Jeanette Milne; Melina Vega de CenigaPublished Online:13 Sep 2023https://doi.org/10.12968/jowc.2023.32.Sup9b.S1AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References 1. Sen CK. Human wounds and its burden: an updated compendium of estimates. Adv Wound Care (New Rochelle). 2019; 8(2):39–48. https://doi.org/10.1089/wound.2019.0946 Crossref, Medline, Google Scholar2. Guest JF, Fuller GW, Vowden P. Cohort study evaluating the burden of wounds to the UK's National Health Service in 2017/2018: update from 2012/2013. BMJ Open. 2020; 10(12):e045253. https://doi.org/10.1136/bmjopen-2020-045253 Crossref, Medline, Google Scholar3. Olsson M, Jarbrink K, Divakar U, Bajpai R, Upton Z, Schmidtchen A, Car J. The humanistic and economic burden of chronic wounds: a systematic review. Wound Repair Regen. 2019; 27(1):114–125. https://doi.org/10.1111/wrr.12683 Crossref, Medline, Google Scholar4. Gillespie P, Carter L, McIntosh C, Gethin G. Estimating the health-care costs of wound care in Ireland. J Wound Care. 2019; 28(6):324–330. https://doi.org/10.12968/jowc.2019.28.6.324 Link, Google Scholar5. Sibbald RG, Elliott JA, Persaud-Jaimangal R et al.. Wound bed preparation 2021. Adv Skin Wound Care. 2021; 34(4):183–195. https://doi.org/10.1097/01.ASW.0000733724.87630.d6 Crossref, Medline, Google Scholar6. Harries RL, Bosanquet DC, Harding KG. Wound bed preparation: TIME for an update. Int Wound J. 2016; 13(S3):8–14. https://doi.org/10.1111/iwj.12662 Crossref, Medline, Google Scholar7. Schultz GS, Sibbald RG, Falanga V et al.. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003; 11(S1):S1–28. https://doi.org/10.1046/j.1524-475x.11. s2.1.x Crossref, Medline, Google Scholar8. Atkin L, Bucko Z, Conde Montero E et al.. Implementing TIMERS: the race against hard-to-heal wounds. J Wound Care. 2019; 23(S3a):S1–S50. https://doi.org/10.12968/jowc.2019.28.Sup3a.S1 Link, Google Scholar9. Jeffery S. Clinical benefits of small intestinal submucosa extracellular matrix and review of the evidence. J Wound Care. 2023; 32(1):S11–S19 Link, Google Scholar10. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. Br Med J. 1996; 312(7023):71–72. https://doi.org/10.1136/bmj.312.7023.71 Crossref, Medline, Google Scholar11. Simman, R. Role of small intestinal submucosa extracellular matrix in advanced regenerative wound therapy. J Wound Care. 2023; 32(1):S3–S10 Abstract, Google Scholar12. Shi L, Ronfard V. Biochemical and biomechanical characterization of porcine small intestinal submucosa (SIS): a mini review. Int J Burns Trauma. 2013; 3(4):173–179 Medline, Google Scholar13. Maquart FX, Pasco S, Ramont L, Hornebeck W, Monboisse JC. An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion. Crit Rev Oncol Hematol. 2004; 49(3):199–202. https://doi.org/10.1016/j.critrevonc.2003.06.007 Crossref, Medline, Google Scholar14. Hodde JP, Badylak SF, Brightman AO, Voytik-Harbin SL. Glycosaminoglycan content of small intestinal submucosa: a bioscaffold for tissue replacement. Tissue Eng. 1996; 2(3):209–217. https://doi.org/10.1089/ten.1996.2.209 Crossref, Medline, Google Scholar15. Hodde J, Janis A, Ernst D, Zopf D, Sherman D, Johnson C. Effects of sterilization on an extracellular matrix scaffold: part I. Composition and matrix architecture. J Mater Sci Mater Med. 2007; 18(4):537–543. https://doi.org/10.1007/s10856-007-2300-x Crossref, Medline, Google Scholar16. Huleihel L, Dziki JL, Bartolacci JG et al.. Macrophage phenotype in response to ECM bioscaffolds. Semin Immunol. 2017; 29:2–13. https://doi.org/10.1016/j.smim.2017.04.004 Crossref, Medline, Google Scholar17. Cook Biotech Incorporated. Instructions for use: OASIS Extracellular Matrix. 2023. https://tinyurl.com/mek5995u (accessed 18 July 2023) Google Scholar18. Romanelli M, Dini V, Bertone MS. Randomized comparison of OASIS wound matrix versus moist wound dressing in the treatment of difficult-to-heal wounds of mixed arterial/venous etiology. Adv Skin Wound Care. 2010; 23(1):34–38. https://doi.org/10.1097/01.Asw.0000363485.17224.26 Crossref, Medline, Google Scholar19. Schmitz L, Hessam S, Scholl L, Reitenbach S, Segert MH, Bechara FG. Wound care with a porcine extracellular matrix after surgical treatment of rhinophyma. J Cutan Med Surg. 2020; 24(3):253–258. https://doi.org/10.1177/1203475420906774 Crossref, Medline, Google Scholar20. Mostow EN, Haraway GD, Dalsing M, Hodde JP, King D. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg. 2005; 41(5):837–843. https://doi.org/10.1016/j.jvs.2005.01.042 Crossref, Medline, Google Scholar21. Cazzell SM, Lange DL, Dickerson JE, Jr., Slade HB. The management of diabetic foot ulcers with porcine small intestine submucosa trilayer matrix: a randomized controlled trial. Adv Wound Care. 2015; 4(12):711–718. https://doi.org/10.1089/wound.2015.0645 Crossref, Medline, Google Scholar22. Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care. 2005; 18(5 Pt 1):258-266. https://doi.org/10.1097/00129334-200506000-00012 Crossref, Medline, Google Scholar23. Brown-Etris M, Milne CT, Hodde JP. An extracellular matrix graft (Oasis(®) wound matrix) for treating full-thickness pressure ulcers: a randomized clinical trial. J Tissue Viability. 2019; 28(1):21–26. https://doi.org/10.1016/j.jtv.2018.11.001 Crossref, Medline, Google Scholar24. Romanelli M, Dini V, Bertone M, Barbanera S, Brilli C. OASIS wound matrix versus Hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology. Int Wound J. 2007; 4(1):3–7. https://doi.org/10.1111/j.1742-481X.2007.00300.x Crossref, Medline, Google Scholar25. Glik J, Kawecki M, Kitala D et al.. A new option for definitive burn wound closure - pair matching type of retrospective case-control study of hand burns in the hospitalised patients group in the Dr Stanislaw Sakiel Centre for Burn Treatment between 2009 and 2015. Int Wound J. 2017; 14(5):849–855. https://doi.org/10.1111/iwj.12720 Crossref, Medline, Google Scholar26. Yeh DD, Nazarian RM, Demetri L et al.. Histopathological assessment of OASIS Ultra on critical-sized wound healing: a pilot study. J Cutan Pathol. 2017; 44(6):523–529. https://doi.org/10.1111/cup.12925 Crossref, Medline, Google Scholar27. Salgado RM, Bravo L, García M, Melchor JM, Krotzsch E. Histomorphometric analysis of early epithelialization and dermal changes in mid-partial-thickness burn wounds in humans treated with porcine small intestinal submucosa and silver-containing hydrofiber. J Burn Care Res. 2014; 35(5):330–337. https://doi.org/10.1097/bcr.0000000000000015 Crossref, Medline, Google Scholar28. Eisendle K, Thuile T, Deluca J, Pichler M. Surgical treatment of pyoderma gangrenosum with negative pressure wound therapy and skin grafting, including xenografts: personal experience and comprehensive review on 161 cases. Adv Wound Care (New Rochelle). 2020; 9(7):405–425. https://doi.org/10.1089/wound.2020.1160 Crossref, Medline, Google Scholar29. Dhooghe N, Oieni S, Peeters P, D'Arpa S, Roche N. Post surgical pyoderma gangrenosum in flap surgery: diagnostic clues and treatment recommendations. Acta Chir Belg. 2017; 117(2):69–76. https://doi.org/10.1080/00015458.2016.1264729 Crossref, Medline, Google Scholar30. Zuo KJ, Fung E, Tredget EE, Lin AN. A systematic review of post-surgical pyoderma gangrenosum: identification of risk factors and proposed management strategy. J Plast Reconstr Aesthet Surg. 2015; 68(3):295–303. https://doi.org/10.1016/j.bjps.2014.12.036 Crossref, Medline, Google Scholar31. Vlahovic T. Can OASIS (porcine small intestine submucosa) have an impact for pyoderma gangrenosum? Podiatry Today. https://tinyurl.com/2p8rhxk3 (accessed 18 July 2023) Google Scholar32. Wolk K, Join-Lambert O, Sabat R. Aetiology and pathogenesis of hidradenitis suppurativa. Br J Dermatol. 2020; 183(6):999–1010. https://doi.org/10.1111/bjd.19556 Crossref, Medline, Google Scholar33. Scala E, Cacciapuoti S, Garzorz-Stark N et al.. Hidradenitis suppurativa: where we are and where we are going. Cells. 2021; 10(8). https://doi.org/10.3390/cells10082094 Crossref, Google Scholar34. Orenstein LAV, Nguyen TV, Damiani G, Sayed C, Jemec GBE, Hamzavi I. Medical and surgical management of hidradenitis suppurativa: a review of international treatment guidelines and implementation in general dermatology practice. Dermatology. 2020; 236(5):393–412. https://doi.org/10.1159/00 0507323 Crossref, Medline, Google Scholar35. Gonzaga TA, Endorf FW, Mohr WJ, Ahrenholz DH. Novel surgical approach for axillary hidradenitis suppurativa using a bilayer dermal regeneration template: a retrospective case study. J Burn Care Res. 2013; 34(1):51–57. https://doi.org/10.1097/BCR.0b013e31826a7be7 Crossref, Medline, Google Scholar36. Nicoli F, Balzani A, Lazzeri D et al.. Severe hidradenitis suppurativa treatment using platelet-rich plasma gel and Hyalomatrix. Int Wound J. 2015; 12(3):338–343. https://doi.org/10.1111/iwj.12117 Crossref, Medline, Google Scholar37. Fine JD. Inherited epidermolysis bullosa. Orphanet J Rare Dis. 2010; 5:12. https://doi.org/10.1186/1750-1172-5-12 Crossref, Medline, Google Scholar38. Nita M, Pliszczynski J, Kosieradzki M, Fiedor P. Review of the latest methods of epidermolysis bullosa and other chronic wounds treatment including BIOOPA dressing. Dermatol Ther (Heidelb). 2021; 11(5):1469–1480. https://doi.org/10.1007/s13555-021-00578-w Crossref, Medline, Google Scholar39. Isaacs M, Veerkamp P, Somani AK. Small intestinal submucosa matrix as a novel therapy for wounds in dystrophic epidermolysis bullosa. Dermatol Surg. 2019; 45(6):863–864. https://doi.org/10.1097/dss.0000000000001731 Crossref, Medline, Google Scholar40. Chaffin AE, Buckley MC. Extracellular matrix graft for the surgical management of Hurley stage III hidradenitis suppurativa: a pilot case series. J Wound Care. 2020; 29(11):624–630. https://doi.org/10.12968/jowc.2020.29.11.624 Link, Google Scholar41. Veerkamp P, Isaacs M, Somani AK. Small intestinal submucosal matrix as a novel reconstructive option for large scrotal defects. Dermatol Surg. 2018; 44(2):318–321. https://doi.org/10.1097/dss.0000000000001229 Crossref, Medline, Google Scholar42. Mari W, Younes S, Naqvi J et al.. Use of a natural porcine extracellular matrix with negative pressure wound therapy hastens the healing rate in stage 4 pressure ulcers. Wounds. 2019; 31(5):117–122 Medline, Google Scholar43. Nobuyma A, Ayabe S, Kang S, Akome K, Motomura H. The simultaneous application of OASIS and skin grafting in the treatment of tendon-exposed wound. Plast Reconstr Surg Glob Open. 2019; 7(7):e2330. https://doi.org/10.1097/gox.0000000000002330 Crossref, Medline, Google Scholar44. Zagrocki L, Ross A, Hicks A. Management of degloving injuries of the lower extremity: a case report of a forklift injury. Foot Ankle Spec. 2013; 6(2):150–153. https://doi.org/10.1177/1938640012473147 Crossref, Medline, Google Scholar45. Heiney J, Redfern R. Difficult leg wounds successfully closed with decortication, bioresorbable ECM and NPWT. J Wound Care. 2013; 22(6):314–316. https://doi.org/10.12968/jowc.2013.22.6.314 Link, Google Scholar46. Lindholm C, Searle R. Wound management for the 21st century: combining effectiveness and efficiency. Int Wound J. 2016; 13(S2):5–15. https://doi.org/10.1111/iwj.12623 Crossref, Medline, Google Scholar47. Guest JF, Weidlich D, Singh H, La Fontaine J, Garrett A, Abularrage CJ, Waycaster CR. Cost-effectiveness of using adjunctive porcine small intestine submucosa tri-layer matrix compared with standard care in managing diabetic foot ulcers in the US. J Wound Care. 2017; 26(S1):S12–S24. https://doi.org/10.12968/jowc.2017.26. Sup1.S12 Link, Google Scholar48. Martinson M, Martinson N. A comparative analysis of skin substitutes used in the management of diabetic foot ulcers. J Wound Care. 2016; 25(S10):S8–S17. https://doi.org/10.12968/jowc.2016.25.Sup10.S8 Link, Google Scholar49. Gilligan AM, Waycaster CR, Landsman AL. Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products. J Wound Care. 2015; 24(3):149–156. https://doi.org/10.12968/jowc.2015.24.3.149 Link, Google Scholar50. Carter MJ, Waycaster C, Schaum K, Gilligan AM. Cost-effectiveness of three adjunct cellular/tissue-derived products used in the management of chronic venous leg ulcers. Value Health. 2014; 17(8):801–813. https://doi.org/10.1016/j.jval.2014.08.001 Crossref, Medline, Google Scholar51. Hankin CS, Knispel J, Lopes M, Bronstone A, Maus E. Clinical and cost efficacy of advanced wound care matrices for venous ulcers. J Manag Care Pharm. 2012; 18(5):375–384. https://doi.org/10.18553/jmcp.2012.18.5.375 Crossref, Medline, Google Scholar52. Tchanque-Fossuo CN, Dahle SE, Lev-Tov H, West KIM, Li CS, Rocke DM, Isseroff RR. Cellular versus acellular matrix devices in the treatment of diabetic foot ulcers: interim results of a comparative efficacy randomized controlled trial. J Tissue Eng Regen Med. 2019; 13(8):1430–1437. https://doi.org/10.1002/term.2884 Crossref, Medline, Google Scholar53. Landsman A, Roukis TS, DeFronzo DJ, Agnew P, Petranto RD, Surprenant M. Living cells or collagen matrix: which is more beneficial in the treatment of diabetic foot ulcers? Wounds. 2008; 20(5):111–116 Medline, Google Scholar54. Somani AK. Application expansion of small intestinal submucosa extracellular matrix in complex and surgical wounds. J Wound Care. 2023; 32(1):S20–S26 Link, Google Scholar55. Kimball AB, Jemec GBE, Alavi A et al.. Secukinumab in moderateto-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials. Lancet. 2023;401(10378):747–761. https://doi.org/10.1016/S0140-6736(23)00022-3 Crossref, Medline, Google Scholar56. Ocker L, Abu Rached N, Seifert C, Scheel C, Bechara FG. Current medical and surgical treatment of hidradenitis suppurativa: a comprehensive review. J Clin Med. 2022;11(23):7240. https://doi.org/10.3390/jcm11237240 Crossref, Medline, Google Scholar FiguresReferencesRelatedDetails 1 September 2023Volume 32Issue Sup9b ISSN (print): 0969-0700ISSN (online): 2052-2916 Metrics History Published online 13 September 2023 Published in print 1 September 2023 Information© MA Healthcare LimitedPDF download